Professor Shalendar Bhasin
Dr. Bhasin is a Professor of Medicine at the Harvard Medical School, and Director of the Research Program in Men’s Health, Aging and Metabolism at the Brigham and Women’s Hospital in Boston, Massachusetts, USA. He also serves as the Director of an NIH-funded Claude D. Pepper Aging Research Center.
Dr. Bhasin is a translational investigators who has made several seminal contributions to the field of reproductive endocrinology and aging. Dr. Bhasin’s discoveries include: the first clear demonstration that testosterone increases muscle mass and strength; characterization of testosterone’s dose response relationships and adverse effects, and elucidation of the mechanisms by which testosterone increases muscle mass and stimulates erythropoiesis as well as clarifying the role of 5α-reductase type 2 in men. Dr. Bhasin’s research has led to new applications of androgens and selective androgen receptor modulators. He has led some of the most important randomized trials of testosterone and other function promoting anabolic therapies, including the the TOM Trial, the TEAAM Trial, TTrials, the TED Trial, the OPTIMEN Trial and many others. He led the efforts to generate harmonized, population-based reference ranges for testosterone, characterized testosterone’s binding to SHBG and described a new model for estimation of free testosterone. He has served as an Associate Editor of the JCEM; Chair of the Clinical Guidelines Committee of the Endocrine Society; Chair of the Clinical Guidelines Panel of the Endocrine Society for diagnosis and treatment of hypogonadism; and Chair of American Board of Internal Medicine Endocrinology and Metabolism Board. He has received continuous NIH funding for nearly 30 years. He has been the recipient of several teaching, mentoring and research awards including the Outstanding Clinical Investigator Award of the Endocrine Society.